2m 2m 2m 2m 2m 2m 2m
IMMUNOVANT (IMVT)
NASDAQ
$44.39+$0.02 (+0.05%)
Price as of Aug 21, 2026 7:30 PM EDT- $9.2BMarket Cap
- 191.14%1-Year Change
- BiotechnologyIndustry
IMMUNOVANT (IMVT)
$44.39+$0.02 (+0.05%)
Earnings Score
Valuation | IMVT | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | IMVT | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 49.75% | ||
12-Month Momentum | 165.30% | ||
3-Month Risk Adjusted Momentum | 127.29% | ||
12-Month Risk Adjusted Momentum | 273.16% |
True Yield
Valuation | IMVT | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | IMVT | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | -1 |